Sage Journals: Discover world-class research

Open access

Research article

First published 2020-10

Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey

Hiroki Hata, Tadashi Mio, Daisuke Yamashita [...]

Cancer Control

Open access

Case report

First published 2025

Early severe immune-related pneumonitis,hepatitis,and agranulocytosis with radiographic response in sarcomatoid malignant pleural mesothelioma treated with nivolumab and ipilimumab: a case report highlighting dual liver biopsies and rechallenge decision-making

Tomohiro Oba, Katsuhiro Itogawa, Yoko Machida [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2024-4

Nivolumab Safety in Renal Cell Carcinoma: A Case Report

James Debono, Dustin Balzan, John Joseph Borg [...]

Journal of Pharmacy Technology

Retricted access

Case report

First published 2022-4

Use of Cystatin C to Assess Immunotherapy Toxicity in a Patient With Melanoma

Dylan M. Barth, Danielle Otto, Peng Wang [...]

Journal of Pharmacy Practice

Retricted access

Case report

First published 2023-3

Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma

Laurence Bonhomme-Faivre, Valentina Guarino, Srimanta C Misra

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

Pengfei Cui, Di Huang, Zhaozhen Wu [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

A Systematic Review and Meta-Analysis of Immune-Related Adverse Events of Anti-PD-1 Drugs in Randomized Controlled Trials

Yukun Wang, Dejiu Kong, Chaokun Wang [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2023-3

Analysis of immune-mediated reactions in patients with non-small cell lung cancer treated with nivolumab and its association with effectiveness

Susana Cortijo-Cascajares, Ana Cristina Cercós-Lletí, Sara Ortiz-Pérez [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020

Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis

Tingting Liu, Bo Jin, Jun Chen [...]

Therapeutic Advances in Medical Oncology

Retricted access

Abstract

First published 2020-4

Incidence of Immune Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors,Case Series from Two Tertiary Care Centeers in Dubai,UAE

M Omara, Elamin Abdelgadir, F Khan [...]

Tumori Journal

Search results